Epigenomic Sequencing

Unravel methylation status to better understand disease mechanisms and accelerate development of targeted therapies and precision diagnostics.

Discovery's Genomics Services Epigenomic Sequencing Service Advantage

Massive scale with the world’s largest commercial fleet of NovaSeq X Plus, 10 Illumina NovaSeq 6000 sequencers as well as NextSeqs, MiSeqs, and iSeqs

Optimized low-input NGS workflows make the most out of your precious sample material. Our automated workflows reduce technical bias increasing assay reproducibility.

Our scientists approach research challenges with the intelligence and agility to tailor project designs, achieving optimal outcomes. We wield a range of domain expertise helping you improve study designs, avoid problems, and optimize results.

Optimized multi-omic integration with clinical flow, cell biology, molecular pathology, and proteomic services – all under one roof

Access to the world’s largest commercial biorepository to build optimal study cohorts

Industry-leading dual RNA and DNA extraction services are available

Genomics Services Epigenomic Service Details

Epigenomic Service Technologies

Bioinformatics Services

Optimized Nucleic Acid Isolation Services

Ebook

From Sample to Signal - Integrated Genomics for Smarter Therapeutic Development

Learn about Discovery’s reliable, scalable, and
customizable genomics solutions that support
both preclinical and clinical development
programs.

Genomics Services Frequently Asked Questions

Quick Links
Privacy Settings